Company / Net Income
Xenetic Biosciences, Inc. Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$4.0M
FY2025
5-year range
-$10.9M / -$4.0M
FY2021-FY2025
Trend
+4.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Income has fluctuated over the past 10 years, ranging from -$54M in FY2017 to -$4M in FY2018.
Based on SEC 10-K filings.
-$4M in FY2025.
Improved from -$7M to -$4M over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, net income increased 4.2% year-over-year.
- Peak net income was recorded in FY2018.
- Lowest net income in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$4.0M | +4.2% |
| FY2024 | -$4.1M | +36.9% |
| FY2023 | -$6.6M | -16.1% |
| FY2022 | -$5.6M | +48.2% |
| FY2021 | -$10.9M | +14.7% |
| FY2020 | -$12.8M | -75.0% |
| FY2019 | -$7.3M | -103.1% |
| FY2018 | -$3.6M | +93.4% |
| FY2017 | -$54.2M | -333.4% |
| FY2016 | -$12.5M | -45.8% |
As of FY2025 · SEC 10-K Annual Filings · Last checked Jun 28, 2026